# Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

> **NCT02805075** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 15 (actual)

## Conditions studied

- Hematopoietic and Lymphoid Cell Neoplasm
- Recurrent Hematologic Malignancy

## Interventions

- **OTHER:** Fructooligosaccharide
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT02805075
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-11-17
- **Final completion:** 2017-11-17
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02805075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02805075, "Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02805075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*